These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6160390)

  • 41. Investigation of blood group antigens and carcinoembryonic antigen in urinary bladder carcinoma.
    Fujioka T; Ohhori T; Lovrekovich L; deKernion JB
    Urol Int; 1986; 41(6):397-402. PubMed ID: 3547992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Results of the search for ABO system antibodies among the adolescent female population].
    Cwik J
    Ginekol Pol; 1987 Jun; 58(6):403-7. PubMed ID: 3666540
    [No Abstract]   [Full Text] [Related]  

  • 43. How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products.
    Fontaine MJ; Mills AM; Weiss S; Hong WJ; Viele M; Goodnough LT
    Transfusion; 2012 Oct; 52(10):2081-5. PubMed ID: 22414003
    [No Abstract]   [Full Text] [Related]  

  • 44. [Economic aspects of producing standard anti-ABO sera].
    Mikhaĭlova AA
    Gematol Transfuziol; 1986 May; 31(5):55-7. PubMed ID: 2941335
    [No Abstract]   [Full Text] [Related]  

  • 45. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera.
    Frénoy N; Schauffler J; Cahour A; Burtin P
    Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies.
    Wagener C; Yang YH; Crawford FG; Shively JE
    J Immunol; 1983 May; 130(5):2308-15. PubMed ID: 6187849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitive detection of carbohydrate determinants on carcinoembryonic antigen preparations by lectin and antibody binding using polyethylene glycol.
    Pompecki R; Shively JE; Todd CW
    Cancer Res; 1981 May; 41(5):1905-9. PubMed ID: 6163530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced binding activity observed between anti-carcinoembryonic monoclonal antibodies.
    Wellerson R; Kaplan P
    Hybridoma; 1986; 5(3):199-213. PubMed ID: 2429910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purification and characterization of a 50,000 mol. wt glycoprotein antigen, and localization of determinants involved in cross-reactivity with carcinoembryonic antigen.
    Laferté S; Krantz MJ
    Mol Immunol; 1983 Apr; 20(4):421-31. PubMed ID: 6191208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants.
    Herlyn M; Shen JW; Sears HF; Civin CI; Verrill HL; Goldberg EM; Koprowski H
    Clin Exp Immunol; 1984 Jan; 55(1):23-35. PubMed ID: 6198117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ABH monoclonals.
    Tills D
    Dev Biol Stand; 1987; 67():85-90. PubMed ID: 2440746
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunoadsorption for removal of A and B blood-group antibodies.
    Bensinger WI; Baker DA; Buckner CD; Clift RA; Thomas ED
    N Engl J Med; 1981 Jan; 304(3):160-2. PubMed ID: 7003388
    [No Abstract]   [Full Text] [Related]  

  • 54. Absorption of anti-blood group A antibodies on P-selectin glycoprotein ligand-1/immunoglobulin chimeras carrying blood group A determinants: core saccharide chain specificity of the Se and H gene encoded alpha1,2 fucosyltransferases in different host cells.
    Löfling JC; Hauzenberger E; Holgersson J
    Glycobiology; 2002 Mar; 12(3):173-82. PubMed ID: 11971861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies to histo-blood group substances A and B: agglutination titers, Ig class, and IgG subclasses in healthy persons of different age categories.
    Rieben R; Buchs JP; Flückiger E; Nydegger UE
    Transfusion; 1991 Sep; 31(7):607-15. PubMed ID: 1891791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of human ABO blood group A antigen on Escherichia coli Y1089 and Y1090.
    Yang N; Boettcher B
    Immunol Cell Biol; 1992 Dec; 70 ( Pt 6)():411-6. PubMed ID: 1289243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epitopes of carcinoembryonic antigen defined by monoclonal antibodies prepared from mice immunized with purified carcinoembryonic antigen or HCT-8R cells.
    Haggarty A; Legler C; Krantz MJ; Fuks A
    Cancer Res; 1986 Jan; 46(1):300-9. PubMed ID: 2415248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological and biochemical characterization of the nonspecific cross-reacting antigen epitopes using twenty-three monoclonal antibodies.
    Kuroki M; Arakawa F; Higuchi H; Haruno M; Wakisaka M; Matsuoka Y
    Hybridoma; 1991 Oct; 10(5):557-74. PubMed ID: 1725168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinoembryonic antigen and blood group substances.
    Simmons DA; Perlmann P
    Cancer Res; 1973 Feb; 33(2):313-22. PubMed ID: 4120220
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies.
    Primus FJ; Newell KD; Blue A; Goldenberg DM
    Cancer Res; 1983 Feb; 43(2):686-92. PubMed ID: 6184152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.